rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2004-10-7
|
pubmed:abstractText |
We examined whether past use of hormone therapy influences the effects of raloxifene on the risk of new vertebral fracture, cardiovascular events, or breast cancer.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0094-3509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
789-96
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15469774-Adult,
pubmed-meshheading:15469774-Aged,
pubmed-meshheading:15469774-Bone Density,
pubmed-meshheading:15469774-Breast Neoplasms,
pubmed-meshheading:15469774-Cardiovascular Diseases,
pubmed-meshheading:15469774-Cerebrovascular Disorders,
pubmed-meshheading:15469774-Estrogen Replacement Therapy,
pubmed-meshheading:15469774-Female,
pubmed-meshheading:15469774-Humans,
pubmed-meshheading:15469774-Logistic Models,
pubmed-meshheading:15469774-Middle Aged,
pubmed-meshheading:15469774-Osteoporosis, Postmenopausal,
pubmed-meshheading:15469774-Raloxifene,
pubmed-meshheading:15469774-Risk,
pubmed-meshheading:15469774-Selective Estrogen Receptor Modulators,
pubmed-meshheading:15469774-Spinal Fractures
|
pubmed:year |
2004
|
pubmed:articleTitle |
Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
|
pubmed:affiliation |
Department of Orthopedics, Universitetssjukhuset MAS, SE-20502 Malmo, Sweden. olof.johnell@orto.mas.lu.se
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|